Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus pharmacokinetic comparison by rectal, sublingual, and oral administration in healthy volunteers
NL-OMON36191Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus in graft rejection, sponsored by Maastricht University Medical Center+. Primary endpoint: Area under the tacrolimus blood concentration-time curve. Started Apr 2011; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on NL-OMON36191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36191.